CardioDx Taps Ex-Siemens Exec For CEO Role
This article was originally published in Clinica
Executive Summary
Cardiovascular genomics diagnostics firm CardioDx Inc has appointed Khush Mehta as its president and CEO. Mehta succeeds former CEO David Levinson, who will transition to the post of chief strategy officer, leading the company in business development activities, reimbursement efforts and next-generation technology. Prior to joining CardioDx, Mehta served as global head of health care enterprise solutions at Siemens Healthcare GMBH. He has also held additional leadership roles at Siemens, including chief strategy officer and head of Siemens Healthcare Asia Pacific.
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.